| |
 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
 |
|
|
 |
 |
 |
| |
| |
Management |
|
| Executive |
| |
|
|
|
|
|
|
|
|
|
|
 |
|
Mr Victor Skladnev
BSc. MEng. FAICD
Chief Executive Officer / Executive Director
Victor has held chief executive and board positions in both public
and private biotechnology companies over the past 15 years. During
this period he has managed the development and marketing of a number
of award winning products including technology ranked as amongst
the best produced in Australia. Victor has served on a number of
committees including the CSIRO sector advisory board. |
|
| |
|
|
|
|
|
|
|
|
|
|
 |
|
Dr Nejhdeh Ghevondian
BE ME PhD
Chief Technical Officer
Nejhdeh Ghevondian has been involved in managing R&D projects
throughout number of biomedical and computer engineering companies.
Nejhdeh has taken projects from design concepts, right through to
clinical data collection and production, including systems such
as breast cancer detection, ECG analysis and non-invasive monitoring
devices. He has vast project management and technical skills, with
specific expertise in product design, software engineering principles,
enterprise software architecture, complex mathematical computation
and cluster programming. |
|
|
|
|
|
Board |
 |
Mr Martin Greenberg B.Bus, DipComm, FCPA, JP
Independent Chairman
Martin is Managing Director of Apollan Investments Group a Sydney
based company specializing in venture capital, corporate finance,
securities and general investment. From 1986-1999 Martin was a Director
of Babcock & Brown, the International Investment Bank. Prior to
this he was a Director of Morgan Grenfell Australia Limited and prior
to this Senior Vice President with Security Pacific Group in London.
Martin has been a Director of several public companies in Australia
and New Zealand and has an extensive range of national and international
contacts and experience built up over the past 30 years. Currently
he is Chairman of Selector Funds Management Ltd and and a Director of NewGen/ERM Power Group and Liquid Capital Management Pty Ltd.
He was formerly Chairman of Promics Limited. Martin holds a Bachelor
of Business(UTS), Diploma of Commerce(UTS), Fellow CPA and a Justice of Peace. He is also a judge of the annual AVCAL awards. |
|
| |
|
|
|
|
|
|
|
|
|
|
 |
Richard Caldwell
BEc LLB(Syd) ASIA
Non-executive Director
Richard is a founding shareholder and non-executive director of AiMedics. He has recently resigned from Head of Corporate Finance at Stonebridge Equities in Sydney after 24 years in investment banking and trading to pursue a full-time role as executive chairman of Dyesol Limited, an ASX listed solar energy company. Beyond the City, Richard is an honorary governor and past president of The Medical Foundation, one of Australia's largest private medical research foundations and also a visiting fellow of Macquarie University, where he teaches Equity Capital Markets in the Masters of Applied Finance.
|
|
| |
|
|
|
|
|
|
|
|
|
|
 |
Dr Steve Gourlay
MBBS PhD MBA
Non-executive Director
Dr Steve Gourlay is a partner at GBS Ventures Partners, Australia’s largest life sciences venture firm. He has more than 15 years experience in drug and medical device development (Monash University, University of California, San Francisco, Genentech, Life Science Angels). Steve is on the board of directors of four medical device companies in Sydney and is a licensed consultant physician in Internal & Vascular Medicine. He received his PhD in Medicine from Monash University (clinical epidemiology, clinical trial methodology), his postdoc from UCSF (Phase I studies) and his MBA from Macquarie University. |
|
| |
|
|
|
|
|
|
|
|
|
|
 |
Peter Spencer MBA PhD MAICD
Non-executive Director
Dr Peter Spencer has over 25 years experience in the Healthcare Industry in the USA, Australia and Germany.
He has worked in a range of senior positions within Johnson and Johnson Inc for 14 years as well as several
Start-up companies which have resulted in the successful commercialisation of a number of new businesses.
He has qualifications in Science (USyd, BSc), Chemical Engineering BE (USyd, Hons 1), Biomedical Engineering
(UNSW, PhD) and a Masters Degree in Business (Columbia University NY, MBA, Hons Soc). |
|
|
|
|
|
|
|
|
|
|
|
|
| Scientific Advisory Board |
|
|
|
|
|
|
|
|
|
|
|
 |
Professor Hung Nguyen
AM PhD
Scientific Advisor
Hung Nguyen has been Professor of Electrical Engineering at the University
of Technology, Sydney (UTS) since 2001. Currently, he is the Associate
Dean of Research and Development in the Faculty of Engineering (UTS)
and Director (Engineering) of the Key University Research Centre for
Health Technologies. In 2002, he was appointed a Member in the General
Division of the Order of Australia (AM). He is an experienced consultant
for numerous control, computer, biomedical and electronic companies
with more than 150 publications. |
|
| |
|
|
|
|
|
|
|
|
|
|
 |
Associate Professor
Timothy W Jones MD
Scientific Advisor
Associate Professor Jones is Head of Department of Diabetes and Endocrinology
at Princess Margaret Hospital for Children Perth and Clinical Associate
Professor at the Western Australian Institute of Child Heath Research.
His major clinical and research interest is in Diabetes in children and
adolescents with a specific focus on the problem of hypoglycaemia. In
addition to leading his own research group in Australia Dr Jones is an
investigator with the Yale Diabetes Research Center. Dr Jones is also
a member of the Australian Paediatric Endocrine Group Council and the
Scientific Review Committee of the Juvenile Diabetes Research Foundation
International. |
| |
|
|
|
|
|
|
|
|
|
|
 |
|
Professor Stephen
Colagiuri MD
Scientific Advisor
Professor Colagiuri is the chairman of the Department of Endocrinology,
Diabetes and Metabolism, and the director of Diabetes Services, at
the Prince of Wales Hospital, Sydney. Prof. Colagiuri is a member
of institutions such as the Australian Government National Diabetes
Strategy Group, the National Vascular Disease Prevention Partnership
and the International Diabetes Federation (IDF) Screening for Type
II Diabetes Working Party. He has also been past president of the
Australian Diabetes Society (ADS) and a medical advisor to Diabetes
Australia. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
Professor David Owens
MD
Scientific Advisor
Professor Owens is the director of the Diabetes Research Unit, located
at Llandough Hospital, Cardiff, Wales. In 1998, Llandough became the home
of the first Health Authority wide Diabetic Retinopathy Screening Services
in UK under Prof. Owens guidance. He has long been involved in the development
of new treatments for diabetes, resulting into number of international
journal publications. |
| |
|
|
|
|
|
|
|
|
|
|
Webmaster:
admin@aimedics.com
© AiMedics 2009 | Disclaimer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|